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Abstract. Type 2 diabetes mellitus (T2DM) is a degenerative disease that leads 
to increased inflammation and cyclooxygenase protein production, which causes 
tissue abnormalities. The aim of this study was to determine the effect of caprine 
CSN1S2 protein against abnormal metabolic pathways in the aorta of DM rats. 
The twenty-four-animal model was control, diabetes and treatment groups. 
Histopathological evaluation of the aortic tissue by hematoxylin eosin staining. 
The expression of cyclooxygenase and inflammatory cytokine was measured by 
western blotting. In the DM750 groups, the amount of discontinued-endothelial 
was significantly more reduced than in the other groups. The amount of 
macrophages in the DM1500- group decreased more than in the DM and DM375 
groups. The amount of foam cells in the DM750 and DM1500 groups decreased 
more than in the DM group and was close to all control groups. The expressions 
of COX-2 and IL-17 were effectively reduced and vice versa the expression of 
IL-10 was increased in DM750 compared with the other groups. Meanwhile, 
COX-1 expression did not change in all groups. This study indicates that caprine 
CSN1S2 protein at a dose of 750 mg/kg BW has a significant effect on 
controlling, protecting, and repairing abnormalities in the aortic tissue of T2DM 
rats. 
Keywords: aorta; caprine CSN1S2 protein; cyclooxygenase; type 2 diabetes mellitus; 
inflammation. 
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1 Introduction 
Type-2 diabetes mellitus (T2DM) is a disease that has an impact on 
physiological abnormalities as a sign of hyperlipidemia [1]. The risk of T2DM 
is increased when LDL levels in the body are elevated. This leads to the 
occurrence of hyperlipidemia [2,3]. Hyperglycemia followed by hyperlipidemia 
increases the interaction between free fats and free glucose, which produces 
oxidized LDL (ox-LDL). It also causes an immune reaction when entering the 
vessel walls [4,5]. Immune cells that respond to ox-LDL are activated and cause 
inflammation of the aortic tissue [6]. The inflammation of aortic tissue induces 
the aorta to enhance the production of cyclooxygenase 2 (COX-2) protein [7,8]. 
Cyclooxygenase 2 is a protein that has a role as an indicator of cell damage [9]. 
COX-2 generally exists in very small amounts in tissues. COX-2 is an activator 
of prostaglandin E2 (PGE2) [8]. Physiologically, PGE2 plays a role in 
stimulating inflammation in tissues and specifically affects cellular damage in 
Langerhans islets [10]. Increased COX-2 production in the target tissue is a sign 
of abnormality that leads to tissue damage. 
Vascular tissue is one of the target tissues that are susceptible to damage due to 
increased production of COX-2 [10]. A recent study revealed that elevated 
COX-2 expression levels in the aorta indicate a pathological condition and can 
lead to atherosclerosis [11]. Another study showed that COX-2 activity is 
associated with activity of the immune system in the aortic wall layer [12]. The 
influence of COX-2 on immune cell activity causes the tissue damage to 
become more severe [13]. Aortic tissue damage is not only indicated by protein 
levels that indicate a pathological condition. It is also based on other 
parameters, such as deterioration of the discontinued endothelium, immune cell 
activity in the tunica intima and sub tunica intima, and foamy cell formation 
[14-19]. 
Based on a previous study, CSN1S2 derived from caprine milk is a protein that 
has a biological function as bioactive compound. It was found that caprine 
CSN1S2 protein had a positive influence on the ileum microstructure in the rat 
model of rheumatoid arthritis (RA) [20]. It also has an immunomodulatory role 
when inflammatory activity occurs in RA [21]. The result of two other studies 
proved the role of caprine CSN1S2 protein as a selective inhibitor of receptors 
of advanced glucose end products (RAGE) [22] and immunosuppression 
compounds of pro-inflammatory cytokines in RA [21]. Caprine CSN1S2 
protein acts as an antioxidant by reducing the oxidation effect on osteoblast 
when oxidant compounds are feasible [23]. In spite of the various potentials of 
caprine CSN1S2 protein discovered in previous studies, the effects of caprine 
CSN1S2 protein in vascular diabetes still remains unclear. This study explored 
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the effect of caprine CSN1S2 protein on controlling abnormal mechanisms in 
T2DM rats based on histological data, the COX-1, COX-2, IL-10 and IL-17 
expression. 
2 Materials and Methods 
2.1 Isolation of Caprine CSN1S2 Protein 
Bioactive caprine CSN1S2 protein isolated from Ethawah breed goat milk was 
obtained from UPT Ethawah breed goats, Singosari, East Java, Indonesia. The 
caprine CSN1S2 protein isolation procedure was taken from a previous study 
[24] with some modification. The purity of the caprine CSN1S2 protein was 
measured using a Nanodrop spectrophotometer. 
2.2 Animal Study 
The animal models used were twenty-four male rats (Rattus novergicus), Wistar 
strain, 8 weeks old. These animals were purchased from Integrated Research 
and Testing Laboratory, Gadjah Mada University, Yogyakarta, Indonesia. The 
twenty-four animals model was divided into 8 groups, with three repeated, 
consisting of control (C), control rats treated with caprine CSN1S2 protein at 
doses of 375 mg/kg BW (CM375), 750 mg/kg BW (CM750), and 1500 mg/kg 
BW (CM1500), diabetes mellitus (DM), diabetes rats treated with caprine 
CSN1S2 protein at doses of 375 mg/kg BW (DM375), 750 mg/kg BW 
(DM750), and 1500 mg/kg BW (DM1500). The T2DM rats were fed normal 
hyper-cholesterol rat food for two months and then induced with a single dose 
of streptozotocin (25 mg/kg BW) (Sigma-Aldrich). The treatment with caprine 
CSN1S2 protein was conducted for 28 days by oral administration. After the 
treatment, the experimental animals were dissected, organs and aorta were 
collected and stored in 10 mM PBS and 4% paraformaldehyde. This study was 
approved by the research ethics committee of Brawijaya University with ethical 
certificate number 417-KEP-UB. 
2.3 Histopathological Analysis 
Hematoxylin-eosin (HE) staining was conducted for histopathological analysis 
according to previous studies [20,21] with some modifications. The 
histopathological observations of the specimens used an Olympus BX-53 
microscope with 600x magnification. 
2.4 Western Blotting 
Sample protein of aorta tissue from all groups was isolated by the procedure 
described in previous studies [20,25] with some adaptation, after which 
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separation was done using 15% of sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE). To identify protein and cytokine expression in 
the aortas from all rat groups, western blotting analysis was conducted using 
several primary antibodies, such as rabbit anti-rat PTGS1, rabbit anti-rat PTGS2 
(1:1000 Proteintech Group, Inc.) mouse-anti-interleukin (IL)-10 (1:1 500, 
Bioss, Inc.), and rat-anti-IL-17 (1:1 500, Santa Cruz Biotechnology, Inc.). 
Protein separation from SDS-PAGE was transferred to polyvinylidene fluoride 
membrane, followed by washing using phosphate buffer saline Tween-20 and 
incubation with secondary antibodies labeled AP (1:2500) in thermomorphic 
biphasic solvent for 1 hour at room temperature. The membrane was then 
exposed to the targeted protein with a western-blue-substrate solution of nitro 
blue tetrazolium chloride 5-bromo-4-chloro-3-indolyl phosphate (Gathering 
MD, USA). The specific protein density was measured by Bio-Rad Quantity 
One software. 
3 Result 
3.1 Effect of CSN1S2 protein on Histopathology of Aorta Tissue 
Histological observation of the aorta in the control rats showed formation of 
intima, media, and adventitia (Figure. 1(a)). In contrast, the DMT2 group 
showed tunica intima, tunica media, and tunica adventitia. The tunica intima 
had endothelial discontinued cells; foamy cell formation was accompanied by 
an increase of the number of monocytes in the media layer (Figure 1(e)). 
The control rats treated with CSN1S2 proteins from Ethawah breed goat milk 
had a surface similar to that of the control aorta, but measurement of the tunica 
intima of the CM750 group (0.597 ± 0.067µm) (Figure 2(d)) showed that this 
had decreased compared to the other groups. In the DM375 group, the 
formation of foamy cells was less than in the DM group. In the DM375 group, a 
lower number of macrophages in the intima and media layer were identified. In 
the DM750 and DM1500 groups, the histological structures of the intima, 
media, and adventitia was similar to those of the control groups. 
3.2 Effect of Caprine CSN1S2 Protein on Aortic Wall Thickness  
The measurement of the aorta layer thickness showed a difference in the intima 
and media layer between the control, T2DM model, CSN1S2 protein control 
and DM-treated with CSN1S2 groups. The tunica intima layer in the CM750 
(0.597 ± 0.067µm) group was thinner than in the other groups (Figure 1(c)). 
The tunica media lining in the control group (5.287 ± 0.124µm) and DM group 
(5.398 ± 0.879µm) had a similar thickness. The control groups treated with 
CSN1S2 CM750 (6.757 ± 0.747µm) and CM1500 (6.881 ± 0.013µm) showed 
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significant differences with the control and the DM groups (Figure 2(e)). The 
increase of the aortic wall thickness in the treatment group showed the effect of 
the caprine CSN1S2 protein in the metabolic process, which caused an elevated 
volume of the tunica media layer. The obtained results showed that the aorta 
structure of the rats treated with caprine CSN1S2 had increased thickness of the 
intima and media layer correlating with the caprine CSN1S2 dose. 
 
Figure 1 Photomicrograph of rat aorta hematoxylin-eosin staining with scale 
600x. The aorta structure of the control rats had a tunica intima (I) with complete 
endothelium, tunica media (M) and tunica adventitia (A); (a) Control (C), (b) 
control rats treated with caprine CSN1S2 protein at doses of 375 mg/kg BW 
(CM375), (c) 750 mg/kg BW (CM750), (d) 1500 mg/kg BW (CM1500), (e) 
diabetes mellitus (DM), (f) diabetes rats treated with caprine CSN1S2 protein at 
doses of 375 mg/kg BW (DM375), (g) 750 mg/kg BW (DM750), and (h) 1500 
mg/kg BW (DM1500). 
3.3 Abnormal Cell Amount 
The calculation of discontinuous endothelial cells in treatment groups CM750 
(5.66 ± 3.05ab), CM1500 (6.00 ± 2ab), and DM1500 showed a higher number 
of control endothelial cells, but there was no statistically significant difference 
with the control group (Figure 2(a)). In the T2DM model group, the number of 
damaged cells was significant; it was increased compared to the other groups 
(65.66 ± 23.86c). The damage was influenced by the existence of tissue damage 
caused by COX-2 in endothelial cells.  
Endothelial damage is caused by increased oxidant activity in cell 
environments, such as ox-LDL. The DM375 treatment group showed a 
significant decrease of discontinuous endothelial cells (33.66 ± 5.85b p < 0.05) 
as an indicator of improvement of aortic tissue in this group (Figure 2(a)). 
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Figure 2 Abnormality cell in HE slides of aorta tissues. (a) The number of 
discontinued endothelial cells for several groups; (b) The number of 
macrophages in the aorta layer; (c) The amount of foamy cell formation for 
several groups; (d) Tunica intima thickness measurement; (e) Tunica media 
thickness measurement; (f) Tunica adventitia thickness measurement. 
The macrophage count in the control group showed a significant difference 
(0.333 ± 0.57a p < 0.05) compared to the T2DM and T2DM-treated model 
groups. The control group treated with caprine CSN1S2 showed no significant 
difference compared to the control group at all doses. The T2DM group showed 
a significant elevation of the number of infiltrating macrophages in the aortic 
wall (319.00 ± 17.52e p < 0.05). The increased number of macrophages in 
aortic tissue is an indication of increased immune cell activity in the aortic wall. 
The DM375 (120.00 ± 11.53d p < 0.05), DM750 (59.66 ± 12.05c, p < 0.05), 
and DM1500 (30.00 ± 11.4 b, p < 0.05) groups each showed a significant 
reduction of the number of macrophages infiltrating into the aortic layer (Figure 
2(b)).  
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The calculation of foamy cells in the control and treated groups at various doses 
showed that the amount of foamy cell formation did not differ significantly 
between groups. However, the amount of foamy cells in the T2DM model 
group did increase significantly (139.00 ± 19c, p < 0.05) compared to the 
control groups (Figure 2(c)). This condition indicates that macrophage activity 
acts as an ox-LDL receptor scavenger in the aortic layer [26]. The DM375 
group showed a significant decrease in the number of foamy cells formed 
(39.00 ± 9b, p < 0.05) compared to the T2DM model group (Figure 2(c)), but it 
was still higher than in the control group. For the DM750 and DM1500 groups 
the results showed a significant decrease in the number of foamy cells, which 
was similar in the control group (Figure 2(c)). 
3.4 Cyclooxygenase Expression and Inflammation Effect 
Western blotting analysis was done to measure the protein expression level in 
the aortic tissue. The protein measured consisted of cyclooxygenase 1 (72kDa), 
Cyclooxygenase 2 (69kDa), IL-17 (18kDa) and IL-10 (15kDa) (Figure 3(a)). 
The measurements of the COX-1 expression level in the different groups 
showed no significant differences based on the statistical calculations (p < 
0.05).  
The expression level of COX-2 in the DMT2 model group (0.742 ± 0.09 
INT/mm2) was significantly higher than in the other groups (p < 0.05) (Figure 
3(b)). In the DM750 group (0.313 ± 0.025 INT/mm2) and the DM1500 group, 
(0.283 ± 0.03 INT/mm2), the COX-2 expression level was significantly reduced 
compared to the control group (Figure 3(b)). This result proves that caprine 
CSN1S2 protein functioned as a suppressor of COX-2 production. 
IL-17 expression in the control group was 0.243 ± 0.06 INT/mm2. It was low 
for the control groups treated with caprine CSN1S2 protein. For the CM375 
group it was 0.276 ± 0.03 INT/mm2, for the CM750 group it was 0.317 ± 0.04 
INT/mm2, for the CM1500 group it was 0.315 ± 0.05 INT/mm2. This proves 
that the target tissue was stable and under control, especially regarding 
inflammatory activity in the target tissue. The DM model group showed 
significant elevation of IL-17 expression levels (0.701 + 0.04 INT/mm2), 
compared to all other groups (p < 0.05). In the DM750 group (0.303 + 0.04 
INT/mm2), and the DM1500 group (0.299 + 0.05 INT/mm2), the expression 
levels of IL-17 were down-regulated, similar to the control group (Figure 3(c)). 
The IL-10 expression levels in the control groups treated with caprine CSN1S2, 
such as the CM375 group (0.291 ± 0.04 INT/mm2), the CM750 group (0.354 ± 
0.07 INT/mm2), and the CM1500 group (0.324 ± 0.04 INT/mm2) had no 
significant difference with the control group (0.275 ± 0.05 INT/mm2). The IL-
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10 production at certain levels requires the tissue to maintain homeostasis and 
also anti-inflammatory cytokines. [27]. The IL-10 expression level in the T2DM 
rat model group (0.261 ± 0.04 INT/mm2) did not differ from the control group. 
 
Figure 3 Protein expression in aortic tissue. (a) Protein expression profile using 
western blotting method; (b) Measurement of COX-1 and COX-2 expression in 
aortic tissue; (c) Measurement of inflammatory cytokine expression. Control (C), 
control rats treated with caprine CSN1S2 protein at doses of 375 mg/kg BW 
(CM375), 750 mg/kg BW (CM750), and 1500 mg/kg BW (CM1500), diabetes 
mellitus (DM), diabetes rats treated with caprine CSN1S2 protein at doses of 375 
mg/kg BW (DM375), 750 mg/kg BW (DM750), and 1500 mg/kg BW 
(DM1500). 
Meanwhile, the IL-10 expression in the T2DM rat group decreased compared to 
the control group (Figure 3(c)). It was also shown that after treatment with a 
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higher dose of CSN1S2, the IL-10 level increased as well. In the DM750 group 
it was 0.662 + 0.08 INT/mm2 and in the DM1500 group it was 0.679 + 0.09 
INT/mm2. These groups had a higher elevation of IL-10 expression than the 
other groups (p < 0.05). Appearance of a large amount of IL-10 indicates that 
improvements are made in the target tissue (Figure 3(c)). In this case, it 
indicated improvement of the aortic tissue 
4 Discussion  
Our investigation revealed that there was a change in the aortic characteristic 
structure between the control and the T2DM model group. Histological 
observation of the diabetic aorta showed the presence of damage in the 
endothelium structure compared to the control group. The aortic histology of 
theT2DM rat model also showed a number of foamy cells and macrophage 
infiltration in the tunica intima and tunica media layer. The result revealed 
abnormalities in the T2DM model. The onset DM with blood glucose 600 mg/dl 
had a cholesterol level of 400 mg/dl according to the animal model and became 
hyperlipidemic (data not shown). This level is an indicator of elevated lipid 
levels in the circulatory system [2]. Hyperlipidemia followed by hyperglycemia 
(T2DM) causes an elevated risk of reaction of glucose with LDL molecules 
producing ox-LDL [28-30]. The ox-LDL activity in the aorta wall induces 
immune responsive cells such as monocytes and macrophages to act as 
scavenger receptors to phagocytes of the ox-LDL and the formation of foamy 
cells [18,27,29]. Abnormalities were seen from the elevated number of 
macrophages that penetrated into the tunica intima and tunica media. 
Furthermore, abnormalities were also revealed by increased IL-17 and COX-2 
expression levels. IL-17 has an effect on endothelial dysfunction in the vascular 
system [31]. This impact was identified by foamy cell formation and 
significantly higher endothelial damage than in the control groups. 
The effectiveness of treatment with caprine CSN1S2 protein was observed in 
the T2DM group treated with a dose of 375 mg/kg BW. In this model, a 
repaired histological structure of the aorta was found. The structure of the tunica 
intima was found to be improved based on the reduction of discontinued 
endothelial cells. Caprine CSN1S2 protein activities also reduce the number of 
macrophages and foamy cells in the tunica intima and media layers, which were 
significantly lower than in the T2DM model group. Recently, a study revealed 
that caprine CSN1S2 protein plays a role as a selective inhibitor receptor of 
advanced glucose end products [2,9]. According to these studies, the inhibition 
of the AGEs-RAGE binding process in the target cells reduces the downstream 
protein cascade metabolism pathway, as shown in Figure 4. 
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The result supports positive effects of the CSN1S2 protein of Ethawah breed 
goat milk, as shown by the elevated COX-2 expression level in IL-10 and the 
decreased COX-2 expression level in IL-17 compared to the T2DM group. The 
positive effects of the CSN1S2 protein from Ethawah breed goat milk on these 
parameters have a biological immunomodulatory function [20]. The increased 
IL-10 expression level proved the role of CSN1S2 in activating the immune 
system to produce anti-inflammatory cytokines [27]. Furthermore, the CSN1S2 
protein of Ethawah breed goat milk had the effect of down-regulating the COX-
2 expression and inhibiting the PGE2 production by blocking protein cascade 
activity. This process was impacted by the role of PGE2 as an inflammatory 
agent with an autocrine mechanism that increases the inflammatory effect on 
the tissue target that was blocked [8,30]. 
 
Figure 4 Protein signaling pathway of caprine CSN1S2 protein inhibits AGEs-
RAGE binding and activation of COX-2 and pro-inflammation in vascular tissue. 
The dose of CSN1S2 significantly impacted tissue repair under DM. This was 
proved by the histopathology analysis of the DM750 and DM1500 groups, 
which had an intact surface appearance that was similar to that of the control 
group. This was proved by the numbers of macrophages and foamy cells in the 
aorta wall, which were significantly lower compared to the DM and DM375 
groups. This was proven by the decreased levels of IL-17 and COX-2 followed 
by an elevated expression level of IL-10 in the DM375 group. The decrease of 
the IL-17 level was positively affected by the inflamed area in the aorta tissue 
[32]. This was supported by the increased levels of IL-10 expression in the 
groups treated with CSN1S2 at all doses. An elevated level of IL-10 in the DM 
aortic tissue has an atheroprotective effect in the early stages of atherosclerosis 
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[27]. These results suggest that proper doses of CSN1S2 protein have a positive 
effect, not only as immunomodulator and immunosuppressor against 
inflammatory conditions but also by suppressing abnormal mechanisms in the 
aortic tissue. 
Different results were shown in the measurement of COX-1 expression levels in 
the aortic tissues. The COX-1 expression levels were stable for all treatments. It 
was indicated that both the control group and the DM group were not affected 
by the regulation of the COX-1 produced. Similar results were also visible in 
the measurements of COX-1 expression levels in the groups treated with 
CSN1S2, both in the control and the DM group for various doses of CSN1S2. 
Based on previous studies, COX-1 in vascular tissue acts as a ‘housekeeping’ 
protein that plays a role in regulating tissue homeostasis [33,34]. COX-1 has 
many vital roles in cell metabolism reactions, thus the presence of COX-1 at an 
optimal level is needed [35]. However, treatment with caprine CSN1S2 induced 
cellular homeostatic balance in the target tissue. 
Our results suggest that treatment with CSN1S2 protein at a dose of 750 mg/kg 
BW had a positive impact on suppressing immune cells that activate COX-2 
and IL-17, which cause cellular damage in aorta tissue, leading to 
atherosclerosis. Other factors showed that CSN1S2 has no risk of inhibiting or 
blocking the cellular mechanisms that maintain homeostatic balance. The results 
of this study are evidence of the role of CSN1S2 protein in improving the aortic 
structure and the aortic immune response to COX-2 expression from 
hyperglycemia leading to an indication of atherosclerosis. 
5 Conclusions 
Treatment with bioactive CSN1S2 protein from Ethawah goat breed milk has a 
positive role in reducing and repairing damaged aortic tissue, which leads to an 
indication of atherosclerosis and suppresses inflammation caused by immune 
response activity. The effect was specifically significant at a dose of 750 mg/kg 
BW.  
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